Esmolol test to spot heart problems in diabetes, cirrhosis, and cancer
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests whether esmolol (a short-acting heart medicine) can help doctors identify certain heart-related problems in people with type 2 diabetes, liver scarring (cirrhosis), or specific cancers. It’s mainly about improving how heart issues are detected during ultrasound testing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You do not have known moderate-to-severe heart structure or valve problems (no prior old heart attack, certain serious rhythm or contraction issues).
- You have a good ultrasound window, so doctors can see most parts of the heart muscle (at least 14 of 17 areas).
- Your heart rhythm is a normal sinus rhythm with a resting heart rate above 50 beats per minute.
- You fit one of these groups: type 2 diabetes (with or without certain stable heart failure), cirrhosis with specific liver severity, or one of several early cancer diagnoses with planned chemotherapy.
- You can expect to live more than 6 months and be willing to follow the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two heart medications, carvedilol and empagliflozin, to see if they improve heart function in people with cirrhosis (liver scarring). It might help those who have early signs of heart stiffness but normal pumping strength.
This study tests if giving a fast-acting heart medication (esmolol) early through an IV can protect the heart muscle during a heart attack. It may help patients who cannot receive a standard treatment due to certain risks.
This trial tests if esmolol, a heart-slowing drug, can improve oxygen levels in patients with acute respiratory distress syndrome (ARDS) who are on a breathing machine. It may help by adjusting heart rate to a specific range.
This study tests a medication called esmolol to see if it helps blood flow in tiny blood vessels under the tongue for people with septic shock. If you have a fast heart rate despite treatment, this trial may help your doctors better manage your condition.
This study tests whether a medicine called esmolol (a beta-blocker) can help your heart recover while you are on a heart-lung machine (V-A ECMO). It is for adults with severe heart failure who are already on certain heart medicines.
This trial tests whether a low dose of esmolol (a short-acting heart-rate medicine) can reduce heart muscle injury after non-heart surgery in older, frail people. It may help lower the chance of heart-related complications around the time of surgery.
Hear when a new Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.